Yap is required for ependymal integrity and is suppressed in LPA-induced hydrocephalus

Nature Communications

Volumn 7, Issue , 2016, Pages

  Park, Raehee ^a   Moon, Uk Yeol ^a   Park, Jun Young ^a   Hughes, Lucinda J ^a   Johnson, Randy L ^b   Cho, Seo Hee ^a   Kim, Seonhee ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; LYSOPHOSPHATIDIC ACID; NERVE CELL ADHESION MOLECULE; NEURON SPECIFIC NUCLEAR PROTEIN; PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; YAP PROTEIN; CADHERIN; CDH2 PROTEIN, MOUSE; LYSOPHOSPHOLIPID; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YAP PROTEIN, MOUSE;

BIOLOGICAL DEVELOPMENT; BRAIN; CELLS AND CELL COMPONENTS; DEVELOPMENTAL BIOLOGY; DEVELOPMENTAL STAGE; GENE EXPRESSION; INJURY; ORGANIC COMPOUND;

ANIMAL TISSUE; ARTICLE; BRAIN AQUEDUCT; BRAIN DEVELOPMENT; CELL ADHESION; CELL PROLIFERATION; CELL SHAPE; CONTROLLED STUDY; EPENDYMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; NONCOMMUNICATING HYDROCEPHALUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SUBVENTRICULAR ZONE; TRANSCRIPTION INITIATION; ANIMAL; BRAIN; CHEMICALLY INDUCED; EPENDYMA; FETUS DISEASE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; BRAIN; CADHERINS; CEREBRAL AQUEDUCT; EPENDYMA; FETAL DISEASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; LYSOPHOSPHOLIPIDS; MICE; PHOSPHOPROTEINS;

EID: 84954432538     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10329     Document Type: Article

References (50)

1. Symss, N. P. & Oi, S. Theories of cerebrospinal fluid dynamics and hydrocephalus: historical trend. J. Neurosurg. Pediatrics 11, 170-177 (2013).
2. Willems, P. J. Heterogeneity in familial hydrocephalus. Am. J. Med. Genet. 31, 471-473 (1988).
3. Jimenez, A. J. et al. A programmed ependymal denudation precedes congenital hydrocephalus in the hyh mutant mouse. J. Neuropathol. Exp. Neurol. 60, 1105-1119 (2001).
4. Crews, L., Wyss-Coray, T. & Masliah, E. Insights into the pathogenesis of hydrocephalus from transgenic and experimental animal models. Brain Pathol. 14, 312-316 (2004).
5. McAllister, 2nd J. P. Pathophysiology of congenital and neonatal hydrocephalus. Semin. Fetal Neonatal Med. 17, 285-294 (2012).
6. Perez-Figares, J. M., Jimenez, A. J. & Rodriguez, E. M. Subcommissural organ, cerebrospinal fluid circulation, and hydrocephalus. Microsc. Res. Tech. 52, 591-607 (2001).
7. Tissir, F. et al. Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus. Nat. Neurosci. 13, 700-707 (2010).
8. Yamamoto, H. et al. Genetic deletion of afadin causes hydrocephalus by destruction of adherens junctions in radial glial and ependymal cells in the midbrain. PLoS ONE 8, e80356 (2013).
9. Nechiporuk, T., Fernandez, T. E. & Vasioukhin, V. Failure of epithelial tube maintenance causes hydrocephalus and renal cysts in Dlg5-/- mice. Dev. Cell 13, 338-350 (2007).
10. Kango-Singh, M. & Singh, A. Regulation of organ size: insights from the Drosophila Hippo signaling pathway. Dev. Dyn. 238, 1627-1637 (2009).
11. Grusche, F. A., Richardson, H. E. & Harvey, K. F. Upstream regulation of the hippo size control pathway. Curr. Biol. 20, R574-R582 (2010).
12. Johnson, R. & Halder, G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov. 13, 63-79 (2014).
13. Miller, E. et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem. Biol. 19, 955-962 (2012).
14. Yu, F. X. et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791 (2012).
15. Lavado, A. et al. Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators. Development 140, 3323-3334 (2013).
16. Huh, M. S., Todd, M. A. & Picketts, D. J. SCO-ping out the mechanisms underlying the etiology of hydrocephalus. Physiology 24, 117-126 (2009).
17. Meiniel, A. The secretory ependymal cells of the subcommissural organ: which role in hydrocephalus? Int. J. Biochem. Cell. Biol. 39, 463-468 (2007).
18. Silva-Alvarez, C. et al. Ependymal cell differentiation and GLUT1 expression is a synchronous process in the ventricular wall. Neurochem. Res. 30, 1227-1236 (2005).
19. Spassky, N. et al. Adult ependymal cells are postmitotic and are derived from radial glial cells during embryogenesis. J. Neurosci. 25, 10-18 (2005).
20. Cappello, S. et al. Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development. Nat. Genet. 45, 1300-1308 (2013).
21. Yung, Y. C. et al. Lysophosphatidic acid signaling may initiate fetal hydrocephalus. Sci. Transl. Med. 3, 99ra87 (2011).
22. Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505 (2010).
23. Heallen, T. et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458-461 (2011).
24. Alarcon, C. et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139, 757-769 (2009).
25. Sudol, M. Newcomers to the WW domain-mediated network of the hippo tumor suppressor pathway. Genes Cancer 1, 1115-1118 (2010).
26. Yimlamai, D. et al. Hippo pathway activity influences liver cell fate. Cell 157, 1324-1338 (2014).
27. Zhang, H., Pasolli, H. A. & Fuchs, E. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc. Natl Acad. Sci. USA 108, 2270-2275 (2011).
28. Muramatsu, T. et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 32, 389-398 (2011).
29. Varelas, X. et al. The crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev. Cell 19, 831-844 (2010).
30. Barry, E. R. et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493, 106-110 (2013).
31. Tiberi, L., Vanderhaeghen, P. & van den Ameele, J. Cortical neurogenesis and morphogens: diversity of cues, sources and functions. Curr. Opin. Cell Biol. 24, 269-276 (2012).
32. Jouet, M. et al. X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat. Genet. 7, 402-407 (1994).
33. Gumbiner, B. M. & Kim, N. G. The Hippo-YAP signaling pathway and contact inhibition of growth. J. Cell Sci. 127, 709-717 (2014).
34. Song, J. Y. et al. Dual function of Yap in the regulation of lens progenitor cells and cellular polarity. Dev. Biol. 386, 281-290 (2014).
35. Imai, F. et al. Inactivation of aPKClambda results in the loss of adherens junctions in neuroepithelial cells without affecting neurogenesis in mouse neocortex. Development 133, 1735-1744 (2006).
36. Reginensi, A. et al. Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLoS Genet. 9, e1003380 (2013).
37. Genevet, A. & Tapon, N. The Hippo pathway and apico-basal cell polarity. Biochem. J. 436, 213-224 (2011).
38. Piccolo, S., Dupont, S. & Cordenonsi, M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol. Rev. 94, 1287-1312 (2014).
39. Grzeschik, N. A., Parsons, L. M., Allott, M. L., Harvey, K. F. & Richardson, H. E. Lgl, aPKC, and crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr. Biol. 20, 573-581 (2010).
40. Klezovitch, O., Fernandez, T. E., Tapscott, S. J. & Vasioukhin, V. Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice. Genes Dev. 18, 559-571 (2004).
41. Peng, X. et al. Inactivation of Cdc42 in embryonic brain results in hydrocephalus with ependymal cell defects in mice. Protein Cell 4, 231-242 (2013).
42. Cappello, S. et al. The Rho-GTPase cdc42 regulates neural progenitor fate at the apical surface. Nat. Neurosci. 9, 1099-1107 (2006).
43. Chae, T. H., Kim, S., Marz, K. E., Hanson, P. I. & Walsh, C. A. The hyh mutation uncovers roles for alpha snap in apical protein localization and control of neural cell fate. Nat. Genet. 36, 264-270 (2004).
44. Frugier, T. et al. Modulation of LPA receptor expression in the human brain following neurotrauma. Cell. Mol. Neurobiol. 31, 569-577 (2011).
45. Goldshmit, Y. et al. Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes. Am. J. Pathol. 181, 978-992 (2012).
46. Abouhamed, M. et al. Myosin IXa regulates epithelial differentiation and its deficiency results in hydrocephalus. Mol. Biol. Cell 20, 5074-5085 (2009).
47. Elmes, S. J., Millns, P. J., Smart, D., Kendall, D. A. & Chapman, V. Evidence for biological effects of exogenous LPA on rat primary afferent and spinal cord neurons. Brain Res. 1022, 205-213 (2004).
48. Inoue, M. et al. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 10, 712-718 (2004).
49. Barry, E. R. & Camargo, F. D. The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Curr. Opin. Cell Biol. 25, 247-253 (2013).
50. Kim, S. et al. The apical complex couples cell fate and cell survival to cerebral cortical development. Neuron 66, 69-84 (2010).